Restless legs syndrome future or investigational therapies
|
Restless legs syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Restless legs syndrome future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Restless legs syndrome future or investigational therapies |
|
FDA on Restless legs syndrome future or investigational therapies |
|
CDC on Restless legs syndrome future or investigational therapies |
|
Restless legs syndrome future or investigational therapies in the news |
|
Blogs on Restless legs syndrome future or investigational therapies |
|
Risk calculators and risk factors for Restless legs syndrome future or investigational therapies |
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Future or Investigational Therapies
Controversies
Recently, several major pharmaceutical companies are reported to be marketing drugs without an explicit approval for RLS, which are "off-label" applications for drugs approved for other diseases. The Restless Leg Foundation [1] received 44% of its $1.4 million in funding from these pharmaceutical groups[2]. This has called into question the neutrality of this group (significant conflict of interest issue) and the course of action which they recommend to RLS patients.